Koninklijke Philips | PHG - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Abbott USD 52.13B 1.3B 2025-12
Baxter International USD 6.13B 1.11B 2025-12
Becton, Dickinson and Co. USD 25.28B 108M 2025-12
Boston Scientific USD 24.23B 1.58B 2025-12
Danaher USD 52.53B 1.46B 2025-12
Demant DKK 9.84B 446M 2025-12
Dexcom USD 2.75B 19.9M 2025-12
Edwards Lifesciences USD 10.2B 340.3M 2025-09
Fresenius EUR 18.62B 320M 2025-09
General Electric Aerospace USD 18.9B 86M 2025-12
Getinge SEK 33.01B 2.75B 2024-12
Globus Medical USD 4.57B 174.42M 2025-12
GN Store Nord DKK 14.88B 4.33B 2025-12
Hitachi JPY 6.36T 236.75B 2025-12
Hologic USD 5.25B 197.2M 2025-12
Idexx Laboratories USD 1.61B 44.2M 2025-12
Insulet USD 1.52B 131.1M 2025-12
Integra LifeSciences USD 1.04B 5.89M 2025-12
Intuitive Surgical USD 17.82B 894.3M 2025-12
J&J USD 78.47B 0 2025-09
Koninklijke Philips EUR 12.38B 1.97B 2025-09
Masimo USD 721.2M 88.8M 2025-12
Medtronic USD 48.86B 964M 2025-09
Philips EUR 10.58B 204M 2025-09
ResMed USD 6.32B 199.61M 2025-12
Smith & Nephew USD 5.54B 331M 2025-12
Steris USD 7.15B 145.4M 2025-12
Stryker USD 21.78B 594M 2025-09
Teleflex USD 3.12B 697.09M 2025-12
Terumo JPY 1.52T 84.79B 2025-12
Zimmer Biomet Holdings USD 12.7B 68.3M 2025-12